Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Plogosertib by Cyclacel Pharmaceuticals for Leukemia: Likelihood of Approval
Plogosertib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Leukemia. According to GlobalData, Phase II...
Data Insights
Plogosertib by Cyclacel Pharmaceuticals for Adenoid Cystic Carcinoma (ACC): Likelihood of Approval
Plogosertib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Adenoid Cystic Carcinoma (ACC). According to...